Matches in Wikidata for { <http://www.wikidata.org/entity/Q63334297> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q63334297 description "clinical trial" @default.
- Q63334297 description "ensayu clínicu" @default.
- Q63334297 description "klinisch onderzoek" @default.
- Q63334297 description "клінічне випробування" @default.
- Q63334297 description "կլինիկական փորձարկում" @default.
- Q63334297 name "A Study of Bevacizumab Versus Placebo in Combination With Carboplatin/Paclitaxel in Participants With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Previous Chemotherapy" @default.
- Q63334297 type Item @default.
- Q63334297 label "A Study of Bevacizumab Versus Placebo in Combination With Carboplatin/Paclitaxel in Participants With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Previous Chemotherapy" @default.
- Q63334297 prefLabel "A Study of Bevacizumab Versus Placebo in Combination With Carboplatin/Paclitaxel in Participants With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Previous Chemotherapy" @default.
- Q63334297 P1132 Q63334297-BCAC7641-A91D-450C-BA46-29F8924B9553 @default.
- Q63334297 P1476 Q63334297-692BA80C-B912-406F-8377-DF6B926FB4AF @default.
- Q63334297 P2899 Q63334297-A8ACC5C1-E9F8-4C90-9186-399D11BE28BB @default.
- Q63334297 P3098 Q63334297-37DB1901-9EEF-449F-B940-C354C6BB8C98 @default.
- Q63334297 P31 Q63334297-40FA2DE3-C434-40D9-85B4-9D679ED7CE8B @default.
- Q63334297 P4844 Q63334297-091225BE-C328-4666-A8F0-35CCF381E7A7 @default.
- Q63334297 P4844 Q63334297-87AC52E9-A0C0-4568-AED3-02A4E7675359 @default.
- Q63334297 P4844 Q63334297-D9D246E1-0513-43B6-8966-C6398B8FFD6B @default.
- Q63334297 P580 Q63334297-A9A31AA0-06E6-4203-AB3D-D93DDD97F886 @default.
- Q63334297 P582 Q63334297-7B1FD229-B94B-4ECA-BA5F-E4D813E800BA @default.
- Q63334297 P6099 Q63334297-021A4A1A-0CB9-4407-8BF7-9015DBD622B7 @default.
- Q63334297 P6153 Q63334297-4CE57092-6DEF-46F9-828E-570011840CC8 @default.
- Q63334297 P6153 Q63334297-7AA97991-E71F-41F2-AA92-5187A7983C2C @default.
- Q63334297 P6153 Q63334297-8EA70BA1-9D25-4674-9BA9-84F155E0C235 @default.
- Q63334297 P6153 Q63334297-E8BC8E77-5D9A-4E56-AB4E-DCA1B7800F8D @default.
- Q63334297 P6153 Q63334297-F3105655-B3C6-4B5A-9C36-DCC563FB398A @default.
- Q63334297 P8363 Q63334297-417A6B29-A24D-4999-A86C-5CF7DD1A5ACB @default.
- Q63334297 P859 Q63334297-565BC366-67BE-4EAD-A2D5-21B161366D18 @default.
- Q63334297 P1132 "+276" @default.
- Q63334297 P1476 "A Randomized, Double-blinded, Placebo-controlled, Multicenter Phase III Study Comparing Bevacizumab Plus Carboplatin/Paclitaxel Versus Placebo Plus Carboplatin/Paclitaxel in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Prior Chemotherapy For Advanced Disease" @default.
- Q63334297 P2899 "+18" @default.
- Q63334297 P3098 "NCT01364012" @default.
- Q63334297 P31 Q30612 @default.
- Q63334297 P4844 Q413299 @default.
- Q63334297 P4844 Q415588 @default.
- Q63334297 P4844 Q423762 @default.
- Q63334297 P580 "2011-05-23T00:00:00Z" @default.
- Q63334297 P582 "2013-01-27T00:00:00Z" @default.
- Q63334297 P6099 Q42824827 @default.
- Q63334297 P6153 Q10867899 @default.
- Q63334297 P6153 Q10924832 @default.
- Q63334297 P6153 Q30254263 @default.
- Q63334297 P6153 Q30296241 @default.
- Q63334297 P6153 Q495015 @default.
- Q63334297 P8363 Q78089383 @default.
- Q63334297 P859 Q212646 @default.